Publications by authors named "Nada Nass"
Article Synopsis
- - The study investigates the oral microbiota differences between healthy individuals and those with sickle cell anemia (SCA) in the Middle East, highlighting the need for more research on this genetic disorder.
- - Saliva samples from 36 participants (18 with SCA and 18 healthy controls) were analyzed using next-generation sequencing to identify and quantify various bacterial species in their oral microbiomes.
- - Findings reveal that alterations in the oral microbiota may increase health complications for SCA patients, suggesting that salivary diagnostics could be useful for predicting and preventing related diseases in the future.
Article Synopsis
- The study analyzed how various methods of administering synbiotics affected the intestinal health of male Mandarah chicks.
- It found that both 0.25 mL and 0.50 mL synbiotics given through drinking water significantly increased beneficial lactic acid bacteria while reducing harmful E. coli levels.
- Treated chicks showed better gut morphology, including improved villus height, leading to the conclusion that using synbiotics in drinking water can enhance the overall health of the birds.
Increasing antimicrobial resistance to the action of existing antibiotics has prompted researchers to identify new natural molecules with antimicrobial potential. In this study, a green system was developed for biosynthesizing gold nanoparticles (BAuNPs) using sage ( L.) leaf extract bioconjugated with non-toxic, eco-friendly, and biodegradable chitosan, forming chitosan/gold bioconjugates (Chi/BAuNPs).
View Article and Find Full Text PDFArticle Synopsis
- * This research focuses on the effectiveness of Fosfomycin in treating E. coli-induced UTIs, examining urine samples from infected patients.
- * Results indicate that Fosfomycin successfully inhibits E. coli with a low minimum inhibitory concentration (MIC), and its intravenous administration significantly reduces bacterial load and inflammation in the kidneys and bladder.
Coronavirus disease 2019 (COVID-19) infection has become a clinical threat to healthy people as well as immunocompromised patients and those with pre-existing chronic diseases around the world. This study, which used a cross-sectional correlational design, aimed to assess the levels of fear and health anxiety and to investigate their predictors during the current outbreak of COVID-19 in immunocompromised and chronic disease patients in Saudi Arabia. Sociodemographic and clinical data, fear of COVID-19, and health anxiety measurements were collected by online surveys from June 15 to July 15, 2020.
View Article and Find Full Text PDFOf the thousands of natural product antibiotics discovered to date, only a handful have been developed for the treatment of bacterial infection. The clinically unexploited majority likely include compounds with untapped potential as antibacterial drugs, and in view of the ever-growing unmet medical need for such agents, warrant systematic re-evaluation. Here we revisit the actinorhodins, a class that was first reported 70 years ago, but which remains poorly characterized.
View Article and Find Full Text PDF